Healthpeak's Strategic Moves Signal Focus on Senior Housing and Life Science Real Estate
Market Chameleon (Tue, 3-Feb 3:52 AM ET)
Healthpeak Properties Provides Strategic Initiatives Update and Reports Fourth Quarter 2025 Results
Business Wire (Mon, 2-Feb 4:15 PM ET)
Healthpeak Advances AI-Enabled Operating Platform, Naming Omkar Joshi Head of Enterprise Innovation
Business Wire (Wed, 21-Jan 4:15 PM ET)
Healthpeak Properties Announces Tax Treatment of 2025 Distributions
Business Wire (Thu, 15-Jan 4:15 PM ET)
Healthpeak Properties Announces $925 Million of Transaction Activity
Business Wire (Mon, 12-Jan 6:59 AM ET)
Business Wire (Fri, 9-Jan 4:15 PM ET)
Business Wire (Wed, 7-Jan 7:01 AM ET)
Business Wire (Wed, 7-Jan 7:00 AM ET)
Healthpeak Properties Declares Monthly Common Stock Cash Dividends for the First Quarter of 2026
Business Wire (Mon, 5-Jan 4:15 PM ET)
KBW Announces Index Rebalancing for Fourth-Quarter 2025
Globe Newswire (Fri, 12-Dec 8:30 PM ET)
Healthpeak owns a diversified healthcare portfolio of approximately 700 in-place properties spread across mainly medical office and life science assets, plus a handful of senior housing, hospital, and skilled nursing/post-acute care assets, as well.
Healthpeak Properties trades on the NYSE stock market under the symbol DOC.
As of February 23, 2026, DOC stock price climbed to $17.24 with 2,983,490 million shares trading.
DOC has a beta of 0.44, meaning it tends to be less sensitive to market movements. DOC has a correlation of 0.10 to the broad based SPY ETF.
DOC has a market cap of $11.98 billion. This is considered a Large Cap stock.
Last quarter Healthpeak Properties reported $719 million in Revenue and $.47 earnings per share. This beat revenue expectation by $26 million and exceeded earnings estimates by $.25.
In the last 3 years, DOC traded as high as $23.26 and as low as $10.52.
The top ETF exchange traded funds that DOC belongs to (by Net Assets): VNQ, VTI, VOO, VB, VBR.
DOC has underperformed the market in the last year with a return of -7.1%, while the SPY ETF gained +12.9%. In the last 3 month period, DOC fell short of the market, returning +0.8%, while SPY returned +4.8%. However, in the most recent 2 weeks DOC has outperformed the stock market by returning +2.9%, while SPY returned -1.3%.
DOC support price is $16.67 and resistance is $17.31 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that DOC shares will trade within this expected range on the day.